Abstract. The tetramer of ethylenesulfonic acid (U-9843) is a potent inhibitor of HIV-| RT* and possesses excellent antiviral activity at nontoxic doses in HIV-I infected lymphocytes grown in tissue culture. Kinetic studies of the HIV-1 RT-catalyzed RNA-directed DNA polymerase activity were carried out in order to determine if the inhibitor interacts with the template:primer or the deoxyribonucleotide triphosphate (dNTP) binding sites of the polymerase. Michaelis-Menten kinetics, which are based on the establishment of a rapid equilibrium between the enzyme and its substrates, proved inadequate for the analysis of the experimental data. The data were thus analyzed using steady-state Briggs-Haldane kinetics assuming that the template:primer binds to the enzyme first, followed by the binding of the dNTP and that the polymerase is a processive enzyme. Based on these assumptions, a velocity equation was derived which allows the calculation of all the specific forward and backward rate constants for the reactions occurring between the enzyme, its substrates and the inhibitor. The calculated rate constants are in agreement with this model and the results indicated that U-9843 acts as a noncompetitive inhibitor with respect to both the template:primer and dNTP binding sites. Hence, U-9843 exhibits the same binding affinity for the free enzyme as for the enzyme-substrate complexes and must inhibit the RT polymerase by interacting with a site distinct from the substrate binding sites. Thus, U-9843 appears to impair an event occurring after the formation of the enzyme-substrate complexes, which involves either an event leading up to the formation of the phosphoester bond, the formation of the ester bond itself or translocation of the enzyme relative to its template:primer following the formation of the ester bond. Key words. HIV RT; polysulfonate; inhibitor; steady-state kinetics.
Several polysulfates and polysulfonates have been identified as potent inhibitors of the RNA-directed DNA polymerase of HIV RT* and have shown antiviral activity in HIV-1 infected lymphocytes grown in tissue culture I-~2. We have previously reported that U-9843, the tetramer of ethylenesulfonic acid, is a potent inhibitor of the RNA and DNA-directed DNA polymerase and RNase H activities of HIV-1 RT ~2. The compound also inhibits other RT enzyme species including the ones isolated from HIV-2, AMV and MLV retroviruses. Kinetic inhibition studies were carried out to establish if U-9843 interacts with the substrate binding sites of the RNA-directed DNA polymerase function of the HIV-1 RT enzyme. At that time the kinetic data were analyzed using Michaelis-Menten kinetics which are based on an equilibrium system and the analysis led us to conclude that U-9843 acts uncompetitively to noncompetitively with respect to the template:primer binding sites in response to increasing concentrations of the inhibitor. This posed a somewhat problematic scenario in that such a system would require that the inhibitor binds very inefficiently to the free enzyme but quite efficiently to the enzyme-substrate complexes at low U-9843 concentrations, while at higher inhibitor concentrations it would bind with equal affinity to the free enzyme and the enzyme-substrate complexes. This problem was resolved in that we applied steady-state Briggs-Haldane kinetics rather than Michaelis-Menten kinetics to analyze the data. The equations developed allow for the calculation of the specific forward and backward rate constants for the essential reactions occurring between the enzyme, its substrates and the inhibitor.
Materials and methods
The expression of HIV-I RT and its purification have been described 13. The enzyme was devoid of Escherichia coli RNase H activity and consisted of p51/p66 heterodimers as evidenced by gel electrophoresis. The synthetic template:primers poly (rA), oligo (dT)~0, poly (rC), and oligo (dG)~o were purchased from Pharmacia. ~-[35S]-labeled dTTP and dGTP were purchased from Dupont NEN. Nonidet P-40 was purchased from Sigma. The standard reaction mixtures for the HIV-I RT RNA directed DNA polymerase assay contained 20raM Incorporation of radiolabeled precursor was determined by collecting the precipitates on glass fiber filters, drying, and counting the samples. As mentioned in the introduction, the kinetic data were initially analyzed using Michaelis-Menten kinetics which are based on a rapid equilibrium system. This analysis yielded ambiguous results ~2. The reason for this inadequacy resides in the fact that the enzyme needs to form an initiation complex with the two respective substrates before elongation of the primer can begin. Therefore, no immediate equilibrium is established between the reactants involved. The experimental data were thus expanded and then analyzed using steady-state BriggsHaldane kinetics. In this latter case the enzyme-substrate complex does not need to be in equilibrium with the enzyme and its substrate. However, shortly after initiation of the reaction, enzyme-substrate complex is formed at the same rate as it dissociates. Steady-state schemes including all the reaction steps to be considered here, yield very complex velocity equations which are impractical to solve. For these reasons the general steady-state kinetic system used in this study was simplified as detailed in figure 1. The steady-state kinetics were limited to the reactions occurring between the enzyme and the substrates and rapid equilibrium kinetics were applied to the interactions pertaining to the inhibitor and the enzyme or the various enzyme-substrate complexes. Moreover, an ordered mechanism was assumed, whereby the template:primer complex binds first to the enzyme, followed by the addition of dNTP TM~5. The polymerase is a processive enzyme and, after the addition of the first nucleotide, translocation occurs along the template, resulting in the incorporation of further nucleotides into the growing chain ~4. Under these conditions the formation of the phosphoester bond can be considered as irreversible as the reverse reaction occurs at an extremely low rate. In addition, the dissociation of the enzymeproduct complex into its components is also negligible during the initial reaction phase. Thus, the enzymeproduct does not differ from the initial enzymetemplate:primer complex in that the former shuttles back to the enzyme-template:primer state and this reaction rate constant is equal to kca t or k2p , representing the turnover number ( fig. 1 ). The pertinent rate are equilibrium constants and the symbols for the enzyme, the inhibitor and substrates used in this paper are defined in Figure 1 . Steady-state reaction scheme for HIV RT. E = enzyme; S] = template:primer; S 2 = dNTP; Ko, Kt, K 2 = equilibrium constants between the inhibitor [I], the enzyme and its substrates; EP = enzyme-product complex; EIP = enzyme-inhibitor-product complex.
figure 1. The quaternary enzyme-inhibitor-template: primer-dNTP complex ought to be non-productive and k;p --, 0. Thus, the HIV RT catalyzed system considered here consists of two substrates, $1, representing the template:primer, $2, representing the dNTP, and an inhibitor I. The reactions between the enzyme (E) and the low molecular weight inhibitor (I) are deemed as diffusion controlled reactions 16-~8. Hence, the conversions between E and EI, ES,, and EIS~, and ES~S2 and EIS~ $2 occur at a much faster rate than the interconversions between the enzyme and its substrates. Thus, although the whole system is a steady-state one, there is an equilibrium between the inhibitor and the enzyme and the enzyme-substrate complexes ~9. The entire system can be expressed as shown in figure 1 where the equilibrium constants or K,s defined as Ko, K~, and/(2, respectively, are given by
Using the apparent rate constants method ~9, the mechanism expressed in figure 1 can be reduced to the one shown in figure 2. According to Chou's graphic rules of enzyme kinetics 2~ the mechanism depicted in figure 2 can be expressed by a directed graph G ( fig. 3a ) and the transformed graph Gt ( fig. 3b ) where E~ =E+EI, E2 = ESl + EIS1, E 3 = ES1 $2 + EIS1 $2 and 
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where eo is the total concentration of all enzyme species and
E1 k21 2 k32 E3 Figure 3 . The graphical expression of the mechanism shown in figure 2 . a The digraph G, and b its transformed graph G'~ 2~ where E 1 -E + EI, E 2 -ES 1 + EIS], E 3 ~ E S 1 S 2 4-EIS1S2 and k12 , k21, k23 , and k32 are given by equation 2.
N3 = = k12k23
Substitution of equation 4 into equation 3 yields k12k23eo (5) [E3] = k32k21 4-k12k32 4-k12k23 and the rate of product formation is (see fig. 1 )
Results
The enzymatic kinetic studies with U-9843 were performed with synthetic homopolymeric template:primers to determine the type of inhibition pattern on the R N Adirected D N A polymerase activity of HIV-1 RT with respect to the template:primer and d N T P binding sites. This activity was first studied in the presence of varied concentrations of the template :primer poly (rA) : (dT)lo and fixed concentrations of dTTP, and vice versa in the presence of varied concentrations of dTTP and fixed concentrations of poly (rA):(dT)l o. Three inhibitor concentrations were used in addition to controls containing no U-9843. The analysis of the data was done via computer applying the modified steady-state kinetics described under 'Materials and methods'. The experimental results are given in table 1 and the calculated forward and backward reaction rates and equilibrium constants are shown in figure 4 . These constants were derived' by fitting the experimental data to equation 6. We note that the calculated forward reaction rate constant kl for the formation of the enzyme-poly (rA):(dT)~0 complex was 4.4 x 104M 1 sec-1 and the rate constant k_l for the reverse reaction was 0.3 sec 1 in the absence of the inhibitor. The k l/k~ ratio amounts thus to 6.8 laM of template:primer. Published estimates for this ratio range from 0.6 nM to 3 I~M of template:primer although these cited values were calculated under the assumption that the system is at equilibrium 22 24. In the presence of U-9843, the in table 2 and the calculated rate constants and equilibrium constants are reported in figure 5 . The forward rate constant kl for the association of the RT-poly (rC):(dG)~o complex was 5.9 x l04 M l sec 1 and its dissociation rate constant k 1 was 0.39 sec 1.
In the presence of the inhibitor, k'l, the forward reaction rate for the formation of the enzyme-U-9843-template:primer complex was 2.5 x 104 M 1 see i and the value for k'l, the reverse reaction, was 0.23 sec -1.
In addition, the rate constant k2 for the formation of enzyme-template:primer-dGTP complex was 2.8 x 104 M l sec ~ and the rate constant k_2s for the reverse reaction was 0.82 secl. In the presence of the inhibitor the rate constant k~ assessing the association of the enzyme-U-9843-template:primer-dGTP complex was 0.77 x l& M -~ sec ~ and k22~, the corresponding dissociation rate constant was 0.27sec -~. The turnover number or translocation rate k2e was 0.4 sec i for the control reaction in this system and k'2p, the analogous value for the enzyme-U-9843-template:primer-dNTP complex was essentially 0. The equilibrium constants were 0.47 ~tM of U-9843 for K0, the enzyme-U-9843 complex, 0.45 ~tM for K~, the enzyme-U-9843-poly (rC) :(dG)~0 complex and 0.31 gM for K2, the enzyme-U-9843-template:primer-dGTP complex. The overall fitting error was 1 x 10 4. The Kis are of equal value and indicate that the inhibitor acts as a noncompetitive inhibitor with respect to the poly (rC) :(dG)m and dGTP binding sites. Moreover, the K~ and/<2 values calculated for the poly (rC):(dG)~0-catalyzed DNA polymerase system are of the same magnitude as the ones obtained for the poly (rA):(dT)~o-catalyzed system demonstrating that the potency of U-9843 is independent of the base composition of the template:primers.
Discussion
The inhibition kinetics of U-9843 on the RNA-directed DNA polymerase domain of HIV-1 RT was studied with respect to the nucleic acid and dNTP binding sites using synthetic homopolymeric template:primers. The analysis of the experimental results was carried out using somewhat modified steady-state Briggs-Haldane kinetics as detailed under 'Materials and methods'. These kinetics take into consideration that 1) the reaction is ordered in that the template:primer binds first to the enzyme and is followed by the addition of dNTP; 2) the enzyme-product complex elongated by one base does not dissociate into free enzyme and product but is recycled back to the enzyme-template:primer state by the process of translocation and the polymerase is, therefore, processive; 3) the formation of the phosphoester bond and the concomitant release of pyrophosphate is irreversible; and 4) the binding of the inhibitor to the free enzyme or the various enzyme-substrate complexes follows rapid equilibrium kinetics. The resuits obtained are consistent with this model. Equation 6 allows the calculation of the essential rate constants and equilibrium constants as it relates the amount of product formed by the RT enzyme to its two substrates, the template:primer and the dNTP, and the inhibitor. The steady-state Briggs-Haldane kinetic analysis applied here shows that the system is indeed a steady-state one and not an equilibrium system for the following reasons: The Ki values or equilibrium constants Ko, K1, K2 are of similar magnitude for all the enzyme-U-9843 and enzyme-U-9843-substrate complexes regardless of whether the reaction was directed by either poly (rA)'(dT)l o or poly(rC):(dG)lo, and these values are independent of the inhibitor concentration. Earlier analyses, using Michaelis-Menten kinetics, incorrectly suggested that U-9843, at low concentrations acts as an uncompetitive inhibitor with respect to the nucleic acid binding site of the enzyme. The steady-state analysis presented here, now clearly shows that U-9843 acts as a noncompetitive inhibitor with respect to both the template:primer and dNTP binding sites and that this inhibition pattern is independent of the U-9843 concentration. Moreover, the results show that U-9843 interacts with a site distinct from either the template:primer and the dNTP binding sites. Therefore, U-9843 appears to impair an event leading up to the formation of the phosphoester bond, the formation of the ester bond per se, or the event of translocation of the enzyme relative
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